In early RA, a raised IGS (MxA, OAS1, ISG15, IFI44L, IFI6) was more prevalent compared with established RA, approximately 50% vs 20% of patients, respectively [13], and fell with the initiation of therapy [12••, 13]. This evidence concerns the gene MX1 and rheumatoid arthritis.